Saturday 17 October 2026
Export IH’s income statement to Excel — free account
iHuman Inc. Sponsored ADR
IH Consumer Defensive Education & Training Services
iHuman Inc. Sponsored ADR’s revenue for fiscal 2025 (year ended December 2025) was $115.4 million, down 8.66% from fiscal 2024. In the quarter to June 2026, revenue fell 8.55%, EPS fell 156.1% and free cash flow grew 613.7%, each against the same quarter a year earlier. Dividend growth for three consecutive years.
1.16
0.02
+1.75%
Follow IH
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
P/E ratio |
+8 more quarters Free account |
9.97 | 8.08 | 8.55 | 23.53 |
P/S ratio |
1.28 | 0.94 | 0.77 | 0.65 | |
P/FCF ratio |
2.57 | 1.70 | 1.38 | 1.13 | |
P/Operating CF |
0.00 | 0.00 | 0.00 | 0.00 | |
P/B ratio |
1.07 | 0.76 | 0.63 | 0.58 | |
Price to Tangible BV |
1.09 | 0.77 | 0.64 | 0.59 | |
EV/Sales |
(0.09) | (0.49) | (0.64) | (0.70) | |
EV/EBITDA |
0.00 | 0.00 | 0.00 | 113.27 | |
EV/Operating CF |
(0.16) | (0.85) | (1.08) | (1.15) | |
EV/FCF |
(0.18) | (0.89) | (1.14) | (1.21) | |
Quick Ratio |
3.18 | 3.30 | 3.21 | 2.60 | |
Current Ratio |
3.46 | 3.57 | 3.50 | 2.91 | |
Net Debt/EBITDA |
(67.69) | (109.30) | 108.99 | 48.47 | |
Debt/Assets |
0.00% | 0.00% | 0.00% | 0.00% | |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.00 | |
Asset Turnover |
0.59 | 0.59 | 0.59 | 0.60 | |
Operating CF/Net income |
0.00 | 0.00 | 0.00 | 0.00 | |
Capex/Depreciation |
— | (0.63) | — | — | |
Research and Development Expense of Revenue |
26.87% | 23.79% | 30.96% | 32.52% | |
Selling, General and Administrative Expense of Revenue |
33.37% | 38.06% | 41.40% | 43.61% | |
Intangible Assets out of Total Assets |
0.01 | 0.01 | 0.01 | 0.01 | |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Graham Net Nets |
0.87 | 1.23 | 1.48 | 1.58 | |
Graham Number |
4.20 | 4.02 | 3.50 | 1.79 | |
Earnings Yield |
10.03% | 12.38% | 11.70% | 4.25% | |
Free Cash Flow Yield |
38.95% | 58.69% | 72.48% | 88.51% | |
Revenue per Share |
0.56 | 0.58 | 0.52 | 0.50 | |
Operating CF per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Capex per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Free Cash Flow per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Cash per Share |
3.10 | 3.20 | 3.12 | 2.90 | |
Shareholders Equity per Share |
2.70 | 2.77 | 2.72 | 2.40 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
2.70 | 2.77 | 2.72 | 2.40 | |
Free Cash Flow |
— | 6.64 | — | — | |
Working Capital |
129.70 | 133.62 | 130.33 | 114.10 | |
Capital Expenditures |
— | (0.70) | — | — | |
Net Current Asset Value |
128.35 | 132.30 | 129.06 | 113.13 | |
EV/EBIT |
0.00 | 0.00 | 0.00 | 113.27 | |
Capex to Sales |
0.00 | 0.00 | 0.00 | 0.00 | |
Price to Operating Income |
14.90 | 11.31 | 17.12 | 0.00 | |
| Other line items | |||||
Average Receivables |
9.49 | 7.38 | 8.18 | 7.36 | |
Average Payables |
3.73 | 3.86 | 3.72 | 2.85 | |
Average Inventory |
2.64 | 3.14 | 3.32 | 3.90 | |
Average Assets |
197.30 | 195.08 | 190.76 | 184.81 | |
Average Common Equity |
135.06 | 136.97 | 134.35 | 128.96 |
Columns are period end dates · fundamentals updated 1 Oct 2026